SOVREMENNAYA PEDIATRIYA.2016.6(78):24-26; doi 10.15574/SP.2016.78.24 

Respiratory tract microbiocenosis in children with cystic fibrosis in Kharkiv region 

Klymenko V. A., Yanovskaya Y. A., Pasichnik Y. V.

Kharkiv National Medical University, Ukraine

CHI «Regional Children's Clinical Hospital #1», Kharkiv, Ukraine

The work is devoted to the study of the clinical and paraclinical peculiarities in children with CF (including respiratory tract microbiocenosis) in Kharkiv region. Also it is about the correlation of microbiological status of CF patients with the disease morbidity. Under the supervision were 30 children with cystic fibrosis. They conducted clinical, paraclinical (bacteriological examination of sputum and epithelial lining fluid, chest X-ray, CT scan of lungs) were performed. Clinical and paraclinic (bacteriological examination of sputum and epithelial lining fluid, chest X-ray, CT scan of lungs) were performed. During observations revealed that the condition severity of CF patients is associated with chronic P. aeruginosa infection, and B. cepacia. And also, that none of patients in Kharkiv region has determined any of pathognomonic respiratory causative microorganisms — M. Tuberculosis and non_tuberculous micobacteria, H. influenza, Ralstonia picketi, condition of infecting by P. Aeruginosa is not identified, and this is the evidence of insufficient laboratory diagnostics.

Key words: cystiс fibrosis, children, microflora.

REFERENCES

1. Gorinova UV, Simonova OI, Tomilova AU, Roslavtseva EA. 2013. The algorithm is complex therapy in cystic fibrosis in children: modern approach. Questions of modern paediatrics. 5: 30-38.

2. Ivkina SS, Krivitskaya LV, Latoho TA. 2015. Cystic fibrosis in children. Health and environmental problems. 4(46): 6-10.

3. Ilchenko SI, Ivanus SG. 2014. Modern problems of diagnosis and clinical course of cystic fibrosis patients at children of Dnepropetrovsk. Young scientist. 6(09): 148- 152.

4. Kapranova N.I. Kashirskaya NU. 2014. Cystic fibrosis. M, Medicine practice: 672.

5. Kapranova NI, Kashirskaya NU. 2014. Current pharmacological approaches to the treatment of cystic fibrosis. Farmateka. 3: 38-43.

6. Manovitskaya NV, Harevich ON, Borodina GL. 2014. The method for determining the severity of the clinical and functional status of patients with cystic fibrosis. Medical magazine. 1(47): 87-89.

7. Shahinian IA, Kapranova NI, Chernuha MU et al. 2010. Microbial landscape of the lower respiratory tract disease in different age groups of children with cystic fibrosis. ZHMEI. 1: 15-20.

8. Elkins M, Dentice R. 2012. Timing of hypertonic saline inhalation for cystic fibrosis. Cochr Database Syst Rev. 2: CD008816. https://doi.org/10.1002/14651858.cd008816.pub2

9. Tramper-Stranders GA, van der Ent CK, Molin S et al. 2012. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates . Clin Microbiol Infect. 18(6): 567—74. https://doi.org/10.1111/j.1469-0691.2011.03627.x; PMid:21883670

10. Rabin HR, Butler SM, Wohl MEB et al. 2004. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol. 37: 400—406. https://doi.org/10.1002/ppul.20023; PMid:15095322